MRPS22
Basic information
Region (hg38): 3:139005806-139360497
Links
Phenotypes
GenCC
Source:
- hypotonia with lactic acidemia and hyperammonemia (Strong), mode of inheritance: AR
- 46 XX gonadal dysgenesis (Supportive), mode of inheritance: AD
- hypotonia with lactic acidemia and hyperammonemia (Supportive), mode of inheritance: AR
- hypotonia with lactic acidemia and hyperammonemia (Strong), mode of inheritance: AR
- ovarian dysgenesis 7 (Limited), mode of inheritance: AR
- mitochondrial disease (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Combined oxidative phosphorylation deficiency 5; Ovarian dysgenesis 7 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Cardiovascular; Craniofacial; Endocrine; Obstetric; Renal; Musculoskeletal; Neurologic | 17873122; 21189481; 29566152 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (7 variants)
- Inborn genetic diseases (2 variants)
- Hypotonia with lactic acidemia and hyperammonemia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MRPS22 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 17 | 17 | ||||
missense | 62 | 66 | ||||
nonsense | 7 | |||||
start loss | 0 | |||||
frameshift | 8 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 4 | 6 | 10 | |||
non coding | 71 | 37 | 27 | 135 | ||
Total | 10 | 5 | 139 | 56 | 28 |
Highest pathogenic variant AF is 0.0000329
Variants in MRPS22
This is a list of pathogenic ClinVar variants found in the MRPS22 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-139005818-C-A | not specified | Uncertain significance (Dec 23, 2022) | ||
3-139005884-C-G | not specified | Uncertain significance (Jan 27, 2022) | ||
3-139005923-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
3-139005991-T-C | not specified | Likely benign (Jun 02, 2023) | ||
3-139006036-A-C | not specified | Uncertain significance (Jun 02, 2023) | ||
3-139006054-G-A | not specified | Uncertain significance (Aug 10, 2021) | ||
3-139006072-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
3-139006094-A-T | not specified | Uncertain significance (Dec 19, 2023) | ||
3-139006133-C-T | not specified | Uncertain significance (Aug 17, 2022) | ||
3-139006180-C-T | not specified | Uncertain significance (Mar 07, 2024) | ||
3-139006187-G-C | not specified | Uncertain significance (Oct 25, 2022) | ||
3-139006215-C-G | not specified | Uncertain significance (Feb 26, 2024) | ||
3-139006253-G-A | not specified | Uncertain significance (Mar 25, 2024) | ||
3-139006261-C-G | not specified | Uncertain significance (Mar 17, 2023) | ||
3-139019886-C-G | not specified | Uncertain significance (Feb 27, 2024) | ||
3-139019904-C-G | not specified | Uncertain significance (Dec 19, 2022) | ||
3-139019926-C-G | not specified | Uncertain significance (Dec 03, 2021) | ||
3-139019926-C-T | not specified | Uncertain significance (Aug 15, 2023) | ||
3-139019950-A-G | not specified | Likely benign (Mar 25, 2022) | ||
3-139019952-G-A | not specified | Uncertain significance (Feb 21, 2024) | ||
3-139019977-G-T | not specified | Uncertain significance (Dec 14, 2023) | ||
3-139020036-C-G | not specified | Uncertain significance (Oct 20, 2021) | ||
3-139020075-T-C | not specified | Uncertain significance (Mar 14, 2023) | ||
3-139020078-G-C | not specified | Uncertain significance (Mar 14, 2023) | ||
3-139020089-C-A | not specified | Uncertain significance (Jun 07, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MRPS22 | protein_coding | protein_coding | ENST00000495075 | 8 | 351418 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000148 | 0.965 | 125700 | 0 | 48 | 125748 | 0.000191 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.131 | 198 | 203 | 0.974 | 0.0000110 | 2348 |
Missense in Polyphen | 63 | 74.494 | 0.8457 | 849 | ||
Synonymous | -1.44 | 86 | 70.6 | 1.22 | 0.00000350 | 691 |
Loss of Function | 1.93 | 11 | 20.4 | 0.539 | 0.00000114 | 229 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000547 | 0.000546 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.000273 | 0.000273 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Disease
- DISEASE: Combined oxidative phosphorylation deficiency 5 (COXPD5) [MIM:611719]: A mitochondrial disease resulting in severe metabolic acidosis, edema, hypertrophic cardiomyopathy, tubulopathy, and hypotonia. {ECO:0000269|PubMed:17873122}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Mitochondrial translation initiation;Translation;Metabolism of proteins;Mitochondrial translation elongation;Mitochondrial translation termination;Mitochondrial translation
(Consensus)
Recessive Scores
- pRec
- 0.204
Intolerance Scores
- loftool
- 0.343
- rvis_EVS
- 0.44
- rvis_percentile_EVS
- 77.7
Haploinsufficiency Scores
- pHI
- 0.0549
- hipred
- N
- hipred_score
- 0.197
- ghis
- 0.477
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0106
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mrps22
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- biological_process;mitochondrial translational elongation;mitochondrial translational termination
- Cellular component
- mitochondrion;mitochondrial inner membrane;mitochondrial ribosome;mitochondrial small ribosomal subunit
- Molecular function
- structural constituent of ribosome